Asset Details
MbrlCatalogueTitleDetail
A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
/ Antineoplastic Agents - chemistry
/ Antineoplastic Agents - pharmacology
/ Cancer
/ Enzyme Inhibitors - chemistry
/ Enzyme Inhibitors - pharmacology
/ Gene Expression Regulation, Neoplastic
/ Humans
/ Intracellular Signaling Peptides and Proteins - chemistry
/ Intracellular Signaling Peptides and Proteins - genetics
/ Intracellular Signaling Peptides and Proteins - metabolism
/ Kinetics
/ MAP Kinase Signaling System - drug effects
/ Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors
/ Mitogen-Activated Protein Kinase 1 - chemistry
/ Mitogen-Activated Protein Kinase 1 - genetics
/ Mitogen-Activated Protein Kinase 1 - metabolism
/ Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors
/ Mitogen-Activated Protein Kinase 3 - chemistry
/ Mitogen-Activated Protein Kinase 3 - genetics
/ Mitogen-Activated Protein Kinase 3 - metabolism
/ Mitogen-Activated Protein Kinase 8 - chemistry
/ Mitogen-Activated Protein Kinase 8 - genetics
/ Mitogen-Activated Protein Kinase 8 - metabolism
/ Protein Serine-Threonine Kinases - chemistry
/ Protein Serine-Threonine Kinases - genetics
/ Protein Serine-Threonine Kinases - metabolism
/ Protein Structure, Secondary
/ Recombinant Proteins - chemistry
/ Recombinant Proteins - genetics
/ Recombinant Proteins - metabolism
/ Upstream